Employment/Internship Opportunities
Publications by the HIV Forum
Adobe Acrobat Reader version 7.0 or newer is required to view these publications. Acrobat Reader is available for free from www.adobe.com in the downloads section.
International Public Health Dialogue on HIV Testing and Counselling
Report
August 17, 2006 - Adobe Acrobat 2.2MB
HIV-TB Co-infection: Meeting the Challenge
Meeting Report
July 22-23, 2007 - Adobe Acrobat 492K
HIV-TB Fact Sheet
Adobe Acrobat 256K
Rethinking the Approach to Expanded Access Programs
Meeting Report
February 16, 2007 - Adobe Acrobat 192K
Collaborative Approaches to HIV Drug Development: Planning for Long-Term Monitoring of Safety in CCR5 Antagonist Development
Report of a Joint FDA/FCHR Joint Public Meeting
May 31, 2006 - Adobe Acrobat 436K
HIV and TB in the Context of Universal Access: What is Working and What is not?
Meeting Report
August 12-13 2006 - Adobe Acrobat 696K
Biomedical Intervention for Prevention
Meeting Report
September 18-19 2006 - Adobe Acrobat 284K
Pediatric HIV Diagnosis and Laboratory Monitoring
Meeting Report
6 February 2006 - Adobe Acrobat 550K
Racial Ethnic Issues in HIV/AIDS
Meeting Report
29-30 October 2003 - Adobe Acrobat 800K
Buprenorphine and HIV Primary Care: New Opportunities for Integrated Treatment
Clinical Infectious DIseases Volume 43 Supplement 4
15 December 2006
HIV-1 Viral Load Assays for Resource-Limited Settings
Regulatory Considerations for Treatment of Lipodystrophy
Workshop Report
March 2005 - Adobe Acrobat 736K
Transfer of HIV Monitoring Technologies Into Resource-Poor Settings: Moving The Field Forward
Workshop Report
February 2005 - Adobe Acrobat 148K
Developing a Health Services Research Agenda
Workshop Report
February 2005—Adobe Acrobat 220K
Initiatives for Developing and Comparing Genotype Interpretation Systems Step 1: External Validation of Existing Rules-Based Algorithm for Abacavir and ddI Evaluated on Virological Response
Antiviral Therapy, 10:S11
Salvage Therapy II
AIDS 2005, 19:747-756
Integration of Buprenorphine into Primary HIV Care
WorkShop Report
June 2004—Adobe Acrobat 736K
Monitoring Long-Term Toxicities of HIV Treatments: An International Perspective
AIDS 2003, 17:2407-2417
Summary of the Executive Committee Retreat Report
Report
March 2003--248K
Sex and Gender and HIV
WorkShop Report
November 2002—Adobe Acrobate PDF 344K
Cardiovascular Risk in HIV Infection and Treatment
Workshop Report
May 2003—Adobe Acrobate PDF 628K
Protein Binding Roundtable Report
Boffito M, Back DJ, Blaschke RF, Rowland M, Bertz RJ, Gerber JG, Miller VM. Protein binding in antiretrovial therapies. AIDS Res & Retroviruses 2003; 19:825-835
STI Workshop
Report from the 3rd International Workshop
March 2002—Adobe Acrobate PDF 282K
STI rountable Discussion: Moving the Agenda Forward
August 2002—Adobe Acrobate PDF 211K
Quality of Care- Closing the Gap
Workshop Report
December 2003—Adobe Acrobate PDF 585K
What Defines HIV Lipodystrophy?
Roundtable Report.
September 2002—Adobe Acrobate PDF 372K
Importance of Antiretroviral Drug Levels in Sanctuary Sites and Viral Reservoirs
Reddy YS, Kashuba A, Gerber J, Miller V on behalf of the roundtable participants. AIDS Research and Human Retroviruses 19:167-176;2003
HIV Monitoring & Diagnostic Technology Transfer to Resource Poor Settings
QA/QC Meeting Report (Warsaw, Poland): October 2003— Adobe Acrobat PDF 251k
Complete Technology Report: April 2002— Adobe Acrobat PDF 932k
Summary Report (English): April 2002— Adobe Acrobat PDF 275k
Summary Report (French) April 2002— Adobe Acrobat PDF 105k
JAMA Article Featuring the Fourm, July 10, 2002-Vol 288, No2:
"Cheaper HIV Drugs for Poor Nations Bring a New Challenge: Monitoring Treatment"
http://jama.ama-assn.org/cgi/reprint/288/2/151.pdf
July 7, 2002 Satellite Symposium Presentations:
Serge Diagbouga, Susan Fiscus, Jonathan Kaplan,
Alan Landay, Souleymane Mboup, Jos Perriens,
Praphan Phanuphak, Mike Ussery, Gaby Vercauteren,
Linkage and Integration of HIV Testing, Prevention, and Care Services
Of the 850,000 to 950,000 HIV infected individuals the USA, approximately one fourth are unaware of their infection, and approximately one third of those who are aware of their infection status are not in ongoing HIV clinical care. The Forum For Collaborative HIV Research in collaboration with the Centers for Disease Control (Atlanta, USA) and the Health Resources Services Administration (HRSA, USA) sponsored a workshop to discuss how to better link HIV counseling, testing, and referral services (CTRs) to HIV care and treatment services. In addition, the group addressed how to evaluate the quality of links and the effectiveness of strategies for integrating prevention services into medical care and social service programs. The "forum" for this discussion included key representatives from both agencies at the federal levels, leaders from grantee organizations and key informants from public and private organizations involved in HIV service delivery.
The workshop started with an update of the status of the epidemiology of HIV infection, prevention and care in the USA, and presentations of how prevention can be integrated into the clinical setting, and how service networks can be created. Panelists addressed organizational and systems issues, social needs and co-occurring health needs, cultural and regional issues and evaluation of links and referrals. Small breakout groups identified links and points of entry into care, barriers to linking HIV CTRs, prevention and care services, and developed recommendations to reduce barriers at the Federal, State program, and community based service provider level and recommendations for evaluation.
Background reviews and documents were prepared for the workshop participants. These include:
" Linking of Testing, Prevention and Care (a review written by Helen Schietinger on behalf of the Forum)
" Referrals and Linkages in HIV Counseling, Testing, and Referral and Partner Counseling and Referral Services: An Annotated Literature Review (prepared by ORC Macro under contract to CDC)
" Targeted Testing and Referral Efforts: A Report of the NASTAD Status Project (Executive Summary)
" Best Practices in Prevention Services for Persons Living with HIV (CDC Prevention, Remarks by R. Janssen)
" Evaluation Plan for the Referrals and Linkages in HIV Counseling and Testing, and Referral and Partner Counseling and Referral Service Project (CDC, DHAP, Marlene Glassman)
" Lessons Learned: Innovations in the Delivery of HIV/AIDS Services (HRSA, HIV/AIDS Bureau, available at: http://www.hab.hrsa.gov )
The report of this meeting is available in several formats. Firstly, we publish the complete workshop report with all appendices (including the background documents above). For easier downloading, we are also making this available in two separate parts: the main report excluding the appendices, and the appendices only. The Summary Report outlines the main features and findings of this workshop. Finally, the background Paper by Helen Scheitinger is available as a simple document.
We hope that the readers will find this report stimulating and useful. If this report has aided readers in specific ways, we would appreciate hearing about it. Please send your comments to info@hivforum.org.
Complete Linkage Report: October 2001— Adobe Acrobat PDF 912k
Linkage report with no appendices: October 2001— Adobe Acrobat PDF 595k
Linkage report appendices: October 2001— Adobe Acrobat PDF 501k
Linkage summary report: October 2001— Adobe Acrobat PDF 163k
Linkage Background paper: September 2001— Adobe Acrobat PDF 140k
Adherence to HIV Therapy
Examining the Risk and Benefits of Directly Observed Therapy (DOT) for Treatment of HIV Disease: The Forum for Collaborative HIV Research in collaboration with the U.S. Health Resources Services Administration (HRSA) sponsored a workshop to discuss Examining the Risk and Benefits of Directly Observed Therapy (DOT) for Treatment of HIV Disease. Seventy-five participants including physicians, clinical researchers, patient advocates, community service providers, health care providers, ethicists, and representatives from state and federal government and the pharmaceutical industry met for two days to discuss recommendations for the development of HIV/DOT programs. These discussions took place in small breakout sessions after a series of presentations covering topics such as the possible applications of DOT for HIV disease, the use of DOT in tuberculosis, ethical considerations of DOT, current status of once-daily antiretroviral treatment regimen, evaluation methods for DOT programs and the needs of different patient populations. The breakout groups addressed questions related to the definition of DOT programs, parameters for determining appropriate candidacy for DOT programs, optimal program design (what treatment regimen, where is the program offered, how is it integrated into other services, duration of the program, helping with adherence) for best meeting the needs of HIV-infected people), and evaluation methods. This report includes a summary of all presentations, breakout group discussions and recommendations. April 2001 — Adobe Acrobat PDF 555k
Adherence to HIV Therapy: Building a Bridge to Success November 1999 — Adobe Acrobat PDF 117k
Adherence to Highly Active Antiretroviral Therapy (HAART) Among Individuals with HIV/AIDS:
A Compendium of HAART Adherence Research, November 1997–November 1999
November 1999 — Adobe Acrobat PDF 64k
Adherence to New HIV Therapies: A Research Conference
November 1998 — Adobe Acrobat PDF 47k
David Barr Speech at 4th Conference on Drug Therapy in Glasgow, Scottland
November 1998 — Adobe Acrobat PDF 17k
Simplifying Antiretroviral Treatment Regimens
– A Summary of Current Research
June 1999 — Adobe Acrobat PDF 78k
Immune-based Therapy
Immune-based Therapies and HIV Disease December 2000 — Adobe Acrobat PDF 278k
Immune-based therapies: A review of clinical endpoints used in trials of selected immunologic agents December 2000 — Adobe Acrobat PDF 156k
Immunological Markers to Evaluate Immune-based Therapies in HIV Disease Meeting Report February 2001 — Adobe Acrobat PDF 45k
Anti-viral Therapy and Salvage Therapy
The Challenges of Clinical Trial Design in Assessing the Effects of Anti-HIV Therapy in Heavily Pre-treated Patients
May 1999 — Adobe Acrobat PDF 100k
Failure of Initial Antiretroviral Treatment Regimens—an Update of Current Research,
January 1999 — Adobe Acrobat PDF 82k
HIV Treatment Failure: A Review of Current Clinical Research
June 1998 — Adobe Acrobat PDF 228k
Structured Treatment Interruptions Workshop Summary
January 2001— Adobe Acrobat PDF 183k
HIV Clinical Practice Guidelines Dissemination and Evaluation Project
Report of the DHHS Working Group on Dissemination of HIV Treatment Information (2001)— Adobe Acrobat PDF 295k
Developing an Agenda for Patient Outcomes Research in HIV Disease
September 1999 — Adobe Acrobat PDF 164k
Dissemination and Evaluation of Clinical Practice Guidelines for HIV Disease
May 1998 — Adobe Acrobat PDF 285k
The Potential of Patient Outcomes Research in HIV Disease September 1999 — Adobe Acrobat PDF 112k
Drug Interaction Research
Report of Meeting on Drug Interaction Research in HIV Disease,
April 2000 — Adobe Acrobat PDF 63k
Metabolic Abnormalities
Metabolic Abnormalities in HIV Disease and Treatment,
October 1998 — Adobe Acrobat PDF 70k
Metabolic Consequences of HIV Disease and Treatment,
June 1998 — Adobe Acrobat PDF 52k
Bone Metabolism and HIV Disease,
August 2000— Adobe Acrobat PDF 239k
Mitochondrial Toxicity and HIV Disease,
June 2000— Adobe Acrobat PDF 203k
Forum for Collaborative HIV Research
Department of Prevention and Community Health
School of Public Health and Health Services2175 K St NW Ste 700
Washington, DC 20037
Phone: 202 530-2370
Fax: 202 530-3923
info@hivforum.org